These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 33162769)

  • 21. Cannabidiol skews biased agonism at cannabinoid CB
    Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
    Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phytocannabinoid Pharmacology: Medicinal Properties of
    Sampson PB
    J Nat Prod; 2021 Jan; 84(1):142-160. PubMed ID: 33356248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.
    De Petrocellis L; Di Marzo V
    J Neuroimmune Pharmacol; 2010 Mar; 5(1):103-21. PubMed ID: 19847654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examining the role of cannabinoids on osteoporosis: a review.
    Clouse G; Penman S; Hadjiargyrou M; Komatsu DE; Thanos PK
    Arch Osteoporos; 2022 Nov; 17(1):146. PubMed ID: 36401719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?
    Maia J; Fonseca BM; Teixeira N; Correia-da-Silva G
    Biochem Pharmacol; 2023 Sep; 215():115686. PubMed ID: 37463627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoids.
    Grotenhermen F
    Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):507-30. PubMed ID: 16266285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoids and their therapeutic applications in mental disorders
.
    Scherma M; Muntoni AL; Riedel G; Fratta W; Fadda P
    Dialogues Clin Neurosci; 2020 Sep; 22(3):271-279. PubMed ID: 33162770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes.
    de Almeida V; Seabra G; Reis-de-Oliveira G; Zuccoli GS; Rumin P; Fioramonte M; Smith BJ; Zuardi AW; Hallak JEC; Campos AC; Crippa JA; Martins-de-Souza D
    Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1311-1323. PubMed ID: 35622101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal functions.
    Darmani NA
    Methods Mol Med; 2006; 123():169-89. PubMed ID: 16506408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus.
    Veilleux A; Di Marzo V; Silvestri C
    Curr Diab Rep; 2019 Nov; 19(11):117. PubMed ID: 31686231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Druggable Targets in Endocannabinoid Signaling.
    Gregus AM; Buczynski MW
    Adv Exp Med Biol; 2020; 1274():177-201. PubMed ID: 32894511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoids and Sleep: Exploring Biological Mechanisms and Therapeutic Potentials.
    D'Angelo M; Steardo L
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome.
    Inserra A; Giorgini G; Lacroix S; Bertazzo A; Choo J; Markopolous A; Grant E; Abolghasemi A; De Gregorio D; Flamand N; Rogers G; Comai S; Silvestri C; Gobbi G; Di Marzo V
    Br J Pharmacol; 2023 Mar; 180(6):721-739. PubMed ID: 36316276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases.
    Thapa D; Warne LN; Falasca M
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does modulation of the endocannabinoid system have potential therapeutic utility in cerebellar ataxia?
    Stephens GJ
    J Physiol; 2016 Aug; 594(16):4631-41. PubMed ID: 26970080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Important Role of the Endocannabinoid System and the Endocannabinoidome in Gut Health.
    Meletis C
    Altern Ther Health Med; 2019 Jun; 25(S2):24-28. PubMed ID: 31202201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.